- Home
- SABS vs HUIZ Comparison
SABS vs HUIZ Comparison
Compare SABS & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- HUIZ
- Stock Information
- Founded
- SABS 2014
- HUIZ 2006
- Country
- SABS United States
- HUIZ China
- Employees
- SABS N/A
- HUIZ N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- HUIZ Specialty Insurers
- Sector
- SABS Health Care
- HUIZ Finance
- Exchange
- SABS Nasdaq
- HUIZ Nasdaq
- Market Cap
- SABS 15.8M
- HUIZ 18.8M
- IPO Year
- SABS N/A
- HUIZ 2020
- Fundamental
- Price
- SABS $1.76
- HUIZ $2.02
- Analyst Decision
- SABS Strong Buy
- HUIZ Hold
- Analyst Count
- SABS 5
- HUIZ 1
- Target Price
- SABS $11.80
- HUIZ $2.30
- AVG Volume (30 Days)
- SABS 17.6K
- HUIZ 17.1K
- Earning Date
- SABS 08-07-2025
- HUIZ 06-06-2025
- Dividend Yield
- SABS N/A
- HUIZ N/A
- EPS Growth
- SABS N/A
- HUIZ N/A
- EPS
- SABS N/A
- HUIZ N/A
- Revenue
- SABS $377,835.00
- HUIZ $168,454,627.00
- Revenue This Year
- SABS N/A
- HUIZ $11.94
- Revenue Next Year
- SABS N/A
- HUIZ $8.15
- P/E Ratio
- SABS N/A
- HUIZ N/A
- Revenue Growth
- SABS N/A
- HUIZ 1.28
- 52 Week Low
- SABS $1.00
- HUIZ $1.50
- 52 Week High
- SABS $5.01
- HUIZ $10.58
- Technical
- Relative Strength Index (RSI)
- SABS 48.13
- HUIZ 47.42
- Support Level
- SABS $1.69
- HUIZ $2.05
- Resistance Level
- SABS $1.87
- HUIZ $2.21
- Average True Range (ATR)
- SABS 0.11
- HUIZ 0.10
- MACD
- SABS -0.01
- HUIZ 0.01
- Stochastic Oscillator
- SABS 53.45
- HUIZ 13.46
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.